Adc Therapeutics Sa Stock Price on December 11, 2024
| ADCT Stock | USD 2.02 0.06 3.06% |
Below is the normalized historical share price chart for ADC Therapeutics SA extending back to May 15, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ADC Therapeutics stands at 2.02, as last reported on the 24th of December, with the highest price reaching 2.18 and the lowest price hitting 1.94 during the day.
If you're considering investing in ADC Stock, it is important to understand the factors that can impact its price. ADC Therapeutics retains Efficiency (Sharpe Ratio) of -0.0181, which signifies that the company had a -0.0181% return per unit of risk over the last 3 months. ADC Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ADC Therapeutics' market risk adjusted performance of 0.285, and Variance of 110.86 to double-check the risk estimate we provide.
At this time, ADC Therapeutics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 7.6 M in 2024, whereas Common Stock is likely to drop slightly above 4.5 M in 2024. . Price To Sales Ratio is likely to drop to 1.85 in 2024. Price Earnings Ratio is likely to drop to -0.59 in 2024. ADC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of March 1979 | 200 Day MA 3.3633 | 50 Day MA 2.618 | Beta 1.602 |
ADC |
Sharpe Ratio = -0.0181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADCT |
Estimated Market Risk
| 10.73 actual daily | 95 95% of assets are less volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ADC Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ADC Therapeutics by adding ADC Therapeutics to a well-diversified portfolio.
Price Book 2.5787 | Enterprise Value Ebitda (1.43) | Price Sales 2.7209 | Shares Float 77.1 M | Wall Street Target Price 8.4 |
ADC Therapeutics Main Headline on 11th of December 2024
ADC Therapeutics Announces Positive Initial Data from LOTIS-... by finance.yahoo.com
ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today announced positive initial data from the LOTIS-7 Phase 1b open-label clinical trial evaluating the safety and efficacy of ZYNLONTA in combination with the bispecific antibody glofitamab in patients with relapsed or refractory diffuse large B-cell lymphoma .
ADC Therapeutics Valuation on December 11, 2024
It is possible to determine the worth of ADC Therapeutics on a given historical date. On December 11, 2024 ADC was worth 3.37 at the beginning of the trading date compared to the closed value of 2.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ADC Therapeutics stock. Still, in general, we apply an absolute valuation method to find ADC Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ADC Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ADC Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.25 | 3.49 | 3.06 | 3.48 | 2,272,669 | |
12/11/2024 | 3.37 | 3.47 | 2.06 | 2.22 | 5,613,435 |
| 2.31 | 2.35 | 1.96 | 1.98 | 1,386,174 |
| Backtest ADC Therapeutics | | | ADC Therapeutics History | | | ADC Therapeutics Valuation | Previous | Next |
ADC Therapeutics Trading Date Momentum on December 11, 2024
| On December 12 2024 ADC Therapeutics SA was traded for 1.98 at the closing time. The top price for the day was 2.35 and the lowest listed price was 1.96 . The trading volume for the day was 1.4 M. The trading history from December 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 10.81% . The overall trading delta against the current closing price is 11.71% . |
ADC Therapeutics Fundamentals Correlations and Trends
By evaluating ADC Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ADC Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ADC financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ADC Therapeutics Stock history
ADC Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ADC is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ADC Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ADC Therapeutics stock prices may prove useful in developing a viable investing in ADC Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 81.7 M | 75.7 M | |
| Net Loss | -140.2 M | -147.2 M |
ADC Therapeutics Quarterly Net Working Capital |
|
ADC Therapeutics Stock Technical Analysis
ADC Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ADC Therapeutics Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
ADC Therapeutics SA cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ADC Therapeutics December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how ADC Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ADC Therapeutics shares will generate the highest return on investment. By undertsting and applying ADC Therapeutics stock market strength indicators, traders can identify ADC Therapeutics SA entry and exit signals to maximize returns
ADC Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ADC Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ADC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ADC to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | 0.275 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.